mRNA |
PF-4708671 |
GDSC1000 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
0.0069 |
0.9 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
0.0048 |
0.9 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
mRNA |
JQ-1 |
GDSC1000 |
pan-cancer |
AAC |
0.0043 |
0.9 |